Impact of Positive Childhood Experiences (PCEs): A Systematic Review of Longitudinal Studies.

Child Psychiatry Hum DevJan 6, 2025 (epub)
Clinical ResearchPsychiatryOpen access

Kannan Kallapiran, Shuichi Suetani, Vanessa Cobham et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined longitudinal studies of cumulative positive childhood experiences (PCEs) and later health and behavioral outcomes. Searches identified eight publications from five studies, including 16,451 participants; three studies assessed adolescent outcomes only. Greater PCE exposure was associated with lower rates of depression, substance use, delinquent and risky sexual behavior, persistent insomnia, and lower inflammatory markers. The review also suggests that PCEs may moderate the association between adverse childhood experiences (ACEs) and later outcomes, but the findings are observational and do not establish causation.

Key findings

  • The review included eight publications from five longitudinal studies, with 16,451 participants.
  • PCEs were associated with reduced rates of depression, substance use, delinquent behavior, risky sexual behavior, and persistent insomnia.
  • Higher PCE exposure was associated with lower inflammatory markers.
  • Childhood PCEs may moderate the impact of ACEs on later mental health and other adverse outcomes.

Why it matters

The findings broaden the focus from childhood adversity alone to potentially protective experiences. Longitudinal evidence linking PCEs with mental, behavioral, sleep, and inflammatory outcomes supports further attention to positive childhood contexts in research on later health. Because the evidence is observational, it cannot show that increasing PCEs would itself prevent these outcomes.

What to keep in mind

The evidence base comprised only five longitudinal studies, and three focused exclusively on adolescent outcomes. The reported associations do not establish causation.

Source

Published in Child Psychiatry Hum Dev. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.